MTOR and glioblastoma: In glioblastoma multiforme, the combination of artesunate with lower doses of metformin demonstrates antitumor effects by activating the AMPK/mTOR pathway and inducing autophagy in human glioblastoma (U251 and U118-MG) cells [180].